WTO – utime limited - ordinary shares (US:NASDAQ)

News

UTime Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency
UTime Limited Announces Pricing of $5 Million Registered Direct Offering
UTime Limited Announces 1-For-25 Reverse Share Split
UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics
UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com